GleamWall
中文EN

NKTR NEKTAR THERAPEUTICS

Pharmaceutical Preparations · Nasdaq · SEC CIK 906709 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-16.6%
TTM net income YoY-46.8%
TTM EPS YoY18.0%
Revenue 3-yr CAGR-16.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-319.8%
Net margin-339.7%
FCF margin-493.4%
EBITDA margin-318.5%

Returns

ROE-37.9%
ROA-26.5%
ROIC (approx.)-30.7%
Asset turnover0.08x

Leverage & solvency

Liabilities / assets18.1%
Debt / equity0.00x
Current ratio9.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.45x
Accruals ratio11.9%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$55.23M$98.43M
Cost of revenue$0$30.69M
Gross profit$55.23M$67.74M
R&D expense$117.33M$120.91M
SG&A expense$68.67M$76.75M
Operating income-$140.10M-$105.20M
Pretax income-$164.21M-$119.20M
Income tax-$138,000-$239,000
Net income-$164.08M-$118.96M
EBITDA-$139.08M-$100.81M
EPS (basic)-9.73-8.68
EPS (diluted)-9.73-8.68
Weighted avg. shares (diluted)16.87M13.71M
Balance sheet
Cash & equivalents$15.12M$44.25M
Short-term investments$230.64M$210.97M
Receivables—$0
Inventory$0$0
Current assets$266.27M$261.29M
PP&E, net$2.06M$3.41M
Total assets$280.41M$303.85M
Current liabilities$53.54M$61.40M
Total liabilities$190.57M$243.11M
Shareholders' equity$89.83M$60.74M
Shares outstanding20.38M12.39M
Cash flow statement
Operating cash flow-$208.51M-$175.71M
Capital expenditure$171,000$1.47M
Free cash flow-$208.68M-$177.18M
Investing cash flow-$1.20M$142.57M
Financing cash flow$180.57M$42.12M
Depreciation & amortization$1.03M$4.39M
Stock-based compensation$12.65M$21.61M
Share buybacks$0$3.00M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.